Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study evaluating fenofibrate in combination with ursodeoxycholic acid for primary biliary cholangitis. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Han Ying | Conditions: Primary Biliary Cholangitis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING